Fig. 1From: Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanomaOverall and Progression Free Survival (a-b) and Overall and progression free survival in patients receiving PD-1 only therapy (c-d)Back to article page